Zhengye Biotechnology Holding Limited ZYBT
1.31
0.00
0.00%
as of 25 Sep
- Market cap
- $40.1M
- P/E
- —
Follow ZYBT
| Dec '25 | Jun '25 | Dec '24 | Jun '24 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | — | — | — |
+1 more TTM period Free account |
|
| 0.00% | — | — | — | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | — | — | |
Free Cash Flow |
5.34 | 9.33 | — | — | |
Capital Expenditures |
(2.27) | (3.00) | — | — | |
Piotroski F-Score |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Cash ROIC |
12.28% | 17.72% | 0.00% | 0.00% | |
Accounts Receivable Turnover |
0.00 | — | — | — | |
Accounts Payable Turnover |
0.00 | — | — | — | |
Inventory Turnover |
0.00 | — | — | — | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | — | — | |
Depreciation/Fixed assets |
0.20 | 0.29 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.22) | (0.30) | — | — | |
Operating CF per Share |
0.00 | 0.00 | — | — | |
Capex per Share |
0.00 | 0.00 | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — |
Columns are period end dates